Hybrid percutaneous treatment of atrial fibrillation
Atrial fibrillation (AF) is the most commonly sustained arrhythmia, with an incidence of 2% in the general population, with a lifetime risk of 24% in individuals over 40 years of age.
Main Author: | Luis Antonio Arabia |
---|---|
Format: | Article |
Language: | English |
Published: |
Linceu Editorial
2018-10-01
|
Series: | Journal of Cardiac Arrhythmias |
Online Access: | https://jca.emnuvens.com.br/jca/article/view/105 |
Similar Items
Hybrid percutaneous treatment of atrial fibrillation
by: Luis Antonio Arabia
Published: (2018-10-01)
by: Luis Antonio Arabia
Published: (2018-10-01)
Similar Items
-
Hybrid percutaneous treatment of atrial fibrillation
by: Luis Antonio Arabia
Published: (2018-10-01) -
Hybrid percutaneous treatment of atrial fibrillation
by: Luis Antonio Arabia
Published: (2018-10-01) -
New atrial fibrillation guidelines: a cool breeze has arrived
by: Luis Antonio Arabia
Published: (2024-03-01) -
Arterial hypotension during percutaneous procedures in the left atrial: It is not always pericardial tamponade!
by: Luis Antonio Arabia, et al.
Published: (2022-03-01) -
Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
by: Panagiotis Theofilis, et al.
Published: (2022-09-01)